University of Maryland, Baltimore: Opioid-Related Disorders trials

The registry lists 16 Opioid-Related Disorders studies with University of Maryland, Baltimore as lead sponsor. 7 are open to participants now and 1 have results posted.

Early Phase 1 1Phase 1 1Phase 2 6Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ketones for Opioid CravingRecruitingNCT07128524Phase 2
• Development of an Opioid Withdrawal Clinical Outcome AssessmentNot yet recruitingNCT07094672
• Ketamine for Opioid Use DisorderRecruitingNCT06943859Phase 2
• Measuring Acute Drug Demand in HumansRecruitingNCT05829655Early Phase 1
• Evaluating Buspirone to Treat Opioid WithdrawalRecruitingNCT05511909Phase 2
• Divided or Single Exposure (DOSE) StudyRecruitingNCT05459402Phase 2/3
• Assessing a Clinically-meaningful Opioid Withdrawal PhenotypeRecruitingNCT05027919Phase 2
• Social Work Assistance and Stipends for Housing (SASH)CompletedNCT05803603Not applicableResults posted
• Older Adults, Methadone, and Cognitive FunctionCompletedNCT07153029Not applicable
• E-cigarette Switching Older AdultsCompletedNCT06534905Not applicable
• Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use FentanylActive, not recruitingNCT06089707Phase 3
• Developing a Clinical Outcome Assessment for Opioid CravingCompletedNCT05109429Not applicable
• Ketamine for OUD and Comorbid Depression (OUDCD)TerminatedNCT05051449Phase 1
• Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use DisorderWithdrawnNCT04169360Phase 2
• Youth Opioid Recovery Support: Improving Care SystemsCompletedNCT04015115Not applicable
• Harnessing Placebo Effects in Methadone TreatmentCompletedNCT02941809Not applicable